Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Presented NCX 470 Phase 3 Mont Blanc Adaptive Design Data and Additional Subset Analysis Showing Superiority over Latanoprost at the World Glaucoma Congress

July 3, 2023

View Press Release Corporate presentation Contact us
Previous